73
Views
2
CrossRef citations to date
0
Altmetric
Methodology

Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes

, , , , &
Pages 1193-1200 | Published online: 13 Jun 2011

References

  • DonehowerRCRowinskyEKGrochowLBLongneckerSMEttingerDSPhase I trial of Taxol in patients with advanced cancerCancer Treat Rep198771117111772891441
  • ArbuckSGCanettaROnettoNChristianMCurrent dosage and schedule issues in the development of paclitaxel (Taxol)Semin Oncol19932031398102016
  • WeissRBDonehowerRCWiernikPHHypersensitivity reactions from TaxolJ Clin Oncol1990823252327
  • FriedlandDGormanGTreatJHypersensitivity reactions from taxol and etoposideJ Natl Cancer Inst19928520367902446
  • SzebeniJMuggiaFMAlvingCRComplement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro studyJ Natl Cancer Inst1998903003069486816
  • SharmaAStraubingerRMNovel taxol formulations: Preparation and characterization of taxol-containing liposomesPharm Res1994118898967937531
  • SharmaUSBalasubramanianSVStraubingerRMPharmaceutical and physical properties of paclitaxel (Taxol®) complexes with cyclodextrinsJ Pharm Sci199584122312308801338
  • Alkan-OnyukselHRamakrishnanSChaiHBPezzutoJMA mixed micellar formulation suitable for the parenteral administration of taxolPharm Res1994112062127909371
  • LeeHJLeeKRParkTGHyaluronic acid-paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activityBioconjug Chem2008191319132518481885
  • SingerJWShafferSBakerBPaclitaxel poliglumex (XYOTAX; CT-2103): An intracellularly targeted taxaneAnticancer Drugs20051624325415711176
  • FasanoMCurrySTerrenoEThe extraordinary ligand binding properties of human serum albuminIUBM Life200557787796
  • HawkinsMJSoon-ShiongPDesaiNProtein nanoparticles as drug carriers in clinical medicineAdv Drug Deliv Rev20086087688518423779
  • MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
  • SebakSMirzaeiMMalhotraMKulamarvaAPrakashSHuman serum albumin nanoparticles as an efficient noscapine drug delivery system for potencial use in breast cancer: Preparation and in vitro analysisInt J Nanomedicine2010552553220957217
  • DesaiNPSoon-ShiongPSandfordPAGrinstaffMWSuslickKSMethods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefore United States Patent 5, 439686.881995
  • DesaiNPTaoCYangAProtein stabilized pharmacologically active agents, preparation thereof and methods for the use thereof United States Patent 6749868.6152004
  • PaálKShkarupinABeckfordLPaclitaxel binding to human serum albumin – automated docking studiesBioorg Med Chem2007151323132917118665
  • Trynda-LemieszLPaclitaxel-HSA interaction. Binding sites on HSA moleculeBioorg Med Chem2004123269327515158795
  • BertucciCCimitanSRivaAMorazzoniPBinding studies of taxanes to human serum albumin by bioaffinity chromatography and circular dichroismJ Pharm Biomed Anal200642818716413734
  • PaálKMüllerJHegedüsLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem20012682187219111277943
  • KumarGNWalleUKBhallaKNWalleTBinding of taxol to human plasma, albumin and alpha 1-acid glycoproteinRes Commun Chem Pathol Pharmacol1993803373448102493
  • PurcellMNeaultJFTajmir-RiahiHAInteraction of taxol with human serum albuminBiochim Biophys Acta20001478616810719175
  • ChenRRemoval of fatty acids from serum albumin by charcoal treatmentJ Biol Chem1967251731816016603
  • AusarSFBiancoIDBadiniGDJ Dairy Sci20018436136911233020
  • WallevikKHvidtAConformational changes in human serum albumin as revealed by hydrogen-deuterium exchange studiesJ Biol Chem1972247153015355012322
  • El KadiNTaulierNLe HuérouJYUnfolding and refolding of bovine serum albumin at acid pH: Ultrasound and structural studiesBiophys J2006913397340416861279
  • MuzammilSKumarYTayyabSMolten globule-like state of human serum albumin at low pHEur J Biochem1999266263210542047
  • WallevikKReversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotationJ Biol Chem1973248265026554697387
  • DockalMCarterDCRükerFConformational transitions of the three recombinant domains of human serum albumin depending on pHJ Biol Chem20002753042305010652284